vs

Side-by-side financial comparison of Idaho Strategic Resources, Inc. (IDR) and NeuroPace Inc (NPCE). Click either name above to swap in a different company.

NeuroPace Inc is the larger business by last-quarter revenue ($26.6M vs $14.6M, roughly 1.8× Idaho Strategic Resources, Inc.). Idaho Strategic Resources, Inc. runs the higher net margin — 64.3% vs -10.3%, a 74.5% gap on every dollar of revenue. On growth, Idaho Strategic Resources, Inc. posted the faster year-over-year revenue change (92.0% vs 23.9%). Idaho Strategic Resources, Inc. produced more free cash flow last quarter ($8.2M vs $409.0K). Over the past eight quarters, Idaho Strategic Resources, Inc.'s revenue compounded faster (57.2% CAGR vs 21.1%).

Idaho Strategic Resources, Inc. is a U.S.-based natural resource company focused on the exploration, development, and production of critical and strategic minerals. Primarily operating in Idaho, it targets rare earth elements, gold, silver, and other high-demand minerals, supplying products to the clean energy, defense, and industrial manufacturing sectors across North America.

NeuroPace Inc is a medical technology company focused on developing and commercializing innovative implantable neurostimulation systems to treat neurological disorders, primarily drug-resistant epilepsy. Its core RNS System delivers personalized responsive stimulation to reduce seizure frequency, serving patients across North America and select global markets via partnerships with healthcare providers.

IDR vs NPCE — Head-to-Head

Bigger by revenue
NPCE
NPCE
1.8× larger
NPCE
$26.6M
$14.6M
IDR
Growing faster (revenue YoY)
IDR
IDR
+68.2% gap
IDR
92.0%
23.9%
NPCE
Higher net margin
IDR
IDR
74.5% more per $
IDR
64.3%
-10.3%
NPCE
More free cash flow
IDR
IDR
$7.8M more FCF
IDR
$8.2M
$409.0K
NPCE
Faster 2-yr revenue CAGR
IDR
IDR
Annualised
IDR
57.2%
21.1%
NPCE

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IDR
IDR
NPCE
NPCE
Revenue
$14.6M
$26.6M
Net Profit
$9.4M
$-2.7M
Gross Margin
68.5%
77.4%
Operating Margin
62.4%
-6.6%
Net Margin
64.3%
-10.3%
Revenue YoY
92.0%
23.9%
Net Profit YoY
220.6%
48.0%
EPS (diluted)
$0.62
$-0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IDR
IDR
NPCE
NPCE
Q4 25
$14.6M
$26.6M
Q3 25
$11.1M
$27.4M
Q2 25
$9.5M
$23.5M
Q1 25
$7.3M
$22.5M
Q4 24
$7.6M
$21.5M
Q3 24
$6.2M
$21.1M
Q2 24
$6.1M
$19.3M
Q1 24
$5.9M
$18.1M
Net Profit
IDR
IDR
NPCE
NPCE
Q4 25
$9.4M
$-2.7M
Q3 25
$3.0M
$-3.5M
Q2 25
$2.8M
$-8.7M
Q1 25
$1.6M
$-6.6M
Q4 24
$2.9M
$-5.3M
Q3 24
$1.6M
$-5.5M
Q2 24
$2.2M
$-7.5M
Q1 24
$2.2M
$-8.9M
Gross Margin
IDR
IDR
NPCE
NPCE
Q4 25
68.5%
77.4%
Q3 25
63.6%
77.4%
Q2 25
57.8%
77.1%
Q1 25
50.8%
77.0%
Q4 24
53.3%
75.4%
Q3 24
48.7%
73.2%
Q2 24
50.2%
73.4%
Q1 24
48.1%
73.6%
Operating Margin
IDR
IDR
NPCE
NPCE
Q4 25
62.4%
-6.6%
Q3 25
23.4%
-9.5%
Q2 25
26.6%
-29.0%
Q1 25
19.3%
-22.9%
Q4 24
36.2%
-17.0%
Q3 24
23.4%
-20.1%
Q2 24
34.2%
-32.4%
Q1 24
36.3%
-41.6%
Net Margin
IDR
IDR
NPCE
NPCE
Q4 25
64.3%
-10.3%
Q3 25
26.8%
-12.8%
Q2 25
29.2%
-36.8%
Q1 25
22.1%
-29.3%
Q4 24
38.5%
-24.5%
Q3 24
25.8%
-25.9%
Q2 24
35.2%
-39.0%
Q1 24
36.8%
-49.2%
EPS (diluted)
IDR
IDR
NPCE
NPCE
Q4 25
$0.62
$-0.08
Q3 25
$0.20
$-0.11
Q2 25
$0.20
$-0.26
Q1 25
$0.12
$-0.21
Q4 24
$0.21
$-0.16
Q3 24
$0.12
$-0.19
Q2 24
$0.17
$-0.26
Q1 24
$0.17
$-0.32

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IDR
IDR
NPCE
NPCE
Cash + ST InvestmentsLiquidity on hand
$61.1M
Total DebtLower is stronger
$2.3M
Stockholders' EquityBook value
$108.2M
$19.0M
Total Assets
$116.2M
$105.6M
Debt / EquityLower = less leverage
0.02×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IDR
IDR
NPCE
NPCE
Q4 25
$61.1M
Q3 25
$60.0M
Q2 25
$62.1M
Q1 25
$66.3M
Q4 24
$52.8M
Q3 24
$56.8M
Q2 24
$6.3M
$55.5M
Q1 24
$5.3M
$58.9M
Total Debt
IDR
IDR
NPCE
NPCE
Q4 25
$2.3M
Q3 25
$3.0M
Q2 25
$3.3M
Q1 25
$3.7M
Q4 24
$1.7M
Q3 24
$2.9M
Q2 24
$2.7M
Q1 24
$3.3M
Stockholders' Equity
IDR
IDR
NPCE
NPCE
Q4 25
$108.2M
$19.0M
Q3 25
$74.3M
$18.5M
Q2 25
$49.3M
$19.4M
Q1 25
$39.8M
$24.3M
Q4 24
$37.7M
$8.0M
Q3 24
$33.1M
$9.8M
Q2 24
$25.4M
$9.9M
Q1 24
$21.6M
$14.3M
Total Assets
IDR
IDR
NPCE
NPCE
Q4 25
$116.2M
$105.6M
Q3 25
$83.1M
$107.3M
Q2 25
$57.7M
$106.1M
Q1 25
$48.1M
$110.2M
Q4 24
$44.0M
$94.6M
Q3 24
$40.8M
$96.3M
Q2 24
$32.2M
$94.4M
Q1 24
$28.7M
$98.9M
Debt / Equity
IDR
IDR
NPCE
NPCE
Q4 25
0.02×
Q3 25
0.04×
Q2 25
0.07×
Q1 25
0.09×
Q4 24
0.05×
Q3 24
0.09×
Q2 24
0.11×
Q1 24
0.15×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IDR
IDR
NPCE
NPCE
Operating Cash FlowLast quarter
$10.7M
$506.0K
Free Cash FlowOCF − Capex
$8.2M
$409.0K
FCF MarginFCF / Revenue
56.0%
1.5%
Capex IntensityCapex / Revenue
17.7%
0.4%
Cash ConversionOCF / Net Profit
1.15×
TTM Free Cash FlowTrailing 4 quarters
$12.4M
$-11.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IDR
IDR
NPCE
NPCE
Q4 25
$10.7M
$506.0K
Q3 25
$2.4M
$-1.9M
Q2 25
$3.5M
$-2.1M
Q1 25
$2.4M
$-7.5M
Q4 24
$3.2M
$-4.8M
Q3 24
$2.5M
$-1.7M
Q2 24
$2.6M
$-3.9M
Q1 24
$2.6M
$-7.5M
Free Cash Flow
IDR
IDR
NPCE
NPCE
Q4 25
$8.2M
$409.0K
Q3 25
$709.8K
$-2.0M
Q2 25
$2.5M
$-2.3M
Q1 25
$1.0M
$-7.5M
Q4 24
$2.1M
$-4.8M
Q3 24
$1.9M
$-1.8M
Q2 24
$2.4M
$-4.0M
Q1 24
$2.3M
$-7.6M
FCF Margin
IDR
IDR
NPCE
NPCE
Q4 25
56.0%
1.5%
Q3 25
6.4%
-7.2%
Q2 25
26.5%
-9.6%
Q1 25
13.8%
-33.4%
Q4 24
28.0%
-22.5%
Q3 24
30.4%
-8.7%
Q2 24
38.7%
-20.6%
Q1 24
38.3%
-42.1%
Capex Intensity
IDR
IDR
NPCE
NPCE
Q4 25
17.7%
0.4%
Q3 25
15.3%
0.1%
Q2 25
10.8%
0.7%
Q1 25
19.4%
0.2%
Q4 24
13.6%
0.2%
Q3 24
9.8%
0.5%
Q2 24
4.3%
0.3%
Q1 24
5.5%
0.6%
Cash Conversion
IDR
IDR
NPCE
NPCE
Q4 25
1.15×
Q3 25
0.81×
Q2 25
1.28×
Q1 25
1.50×
Q4 24
1.08×
Q3 24
1.56×
Q2 24
1.22×
Q1 24
1.19×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons